Otonomy Company Profile (NASDAQ:OTIC)

About Otonomy (NASDAQ:OTIC)

Otonomy logoOtonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company's product candidates include OTIPRIO, OTO-104 and OTO-311. OTIPRIO is a single-dose, physician-administered antibacterial, which is used for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement (TTP) surgery and is available for commercial purchase. OTO-104 is a sustained-exposure formulation of the steroid dexamethasone in development for the treatment of Meniere's disease and other inner ear conditions. OTO-311 is a sustained-exposure formulation of the N-Methyl-D-Aspartate (NMDA) receptor antagonist gacyclidine in development for the treatment of tinnitus. It also has various other product candidates, which target sensorinerual hearing loss, including age-related hearing loss, also known as presbycusis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:OTIC
  • CUSIP: N/A
  • Web: www.otonomy.com
  • Market Cap: $571.21 million
  • Outstanding Shares: 30,303,000
Average Prices:
  • 50 Day Moving Avg: $18.56
  • 200 Day Moving Avg: $15.02
  • 52 Week Range: $11.30 - $20.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.26
  • P/E Growth: -0.28
Sales & Book Value:
  • Annual Revenue: $1.28 million
  • Price / Sales: 446.26
  • Book Value: $4.95 per share
  • Price / Book: 3.81
  • EBIDTA: ($104,540,000.00)
  • Net Margins: -8,172.38%
  • Return on Equity: -57.43%
  • Return on Assets: -53.65%
  • Current Ratio: 16.33%
  • Quick Ratio: 16.21%
  • Average Volume: 193,803 shs.
  • Beta: 2.79
  • Short Ratio: 9.68

Frequently Asked Questions for Otonomy (NASDAQ:OTIC)

What is Otonomy's stock symbol?

Otonomy trades on the NASDAQ under the ticker symbol "OTIC."

How were Otonomy's earnings last quarter?

Otonomy, Inc. (NASDAQ:OTIC) issued its quarterly earnings results on Thursday, August, 3rd. The company reported ($0.77) EPS for the quarter, topping the consensus estimate of ($0.80) by $0.03. The firm had revenue of $0.33 million for the quarter, compared to analysts' expectations of $0.43 million. Otonomy had a negative net margin of 8,172.38% and a negative return on equity of 57.43%. Otonomy's revenue for the quarter was up 312.5% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.98) earnings per share. View Otonomy's Earnings History.

Where is Otonomy's stock going? Where will Otonomy's stock price be in 2017?

2 equities research analysts have issued 12-month price targets for Otonomy's shares. Their forecasts range from $28.00 to $32.00. On average, they anticipate Otonomy's share price to reach $30.00 in the next twelve months. View Analyst Ratings for Otonomy.

Who are some of Otonomy's key competitors?

Who are Otonomy's key executives?

Otonomy's management team includes the folowing people:

  • Jay Lichter Ph.D., Independent Chairman of the Board
  • David A. Weber Ph.D., President, Chief Executive Officer, Director
  • Paul E. Cayer, Chief Financial and Business Officer
  • Robert Michael Savel II, Chief Technical Officer
  • Kathie M. Bishop Ph.D., Chief Scientific Officer
  • Eric J. Loumeau, Chief Compliance Officer, General Counsel, Secretary
  • Dean Hakanson M.D., Chief Medical Officer
  • Vickie L. Capps, Independent Director
  • Iain R. McGill, Independent Director
  • George J. Morrow, Independent Director

Who owns Otonomy stock?

Otonomy's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Jennison Associates LLC (11.90%), TPG Group Holdings SBS Advisors Inc. (7.13%), Federated Investors Inc. PA (5.92%), ORBIMED ADVISORS LLC (4.62%), Vanguard Group Inc. (3.14%) and FMR LLC (2.41%). Company insiders that own Otonomy stock include Carl Lebel, Chau Quang Khuong, David Allen Weber, Eric J Loumeau, Orbimed Advisors Llc, Paul E Cayer and Robert Michael Savel II. View Institutional Ownership Trends for Otonomy.

Who sold Otonomy stock? Who is selling Otonomy stock?

Otonomy's stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Columbus Circle Investors, Federated Investors Inc. PA, Vanguard Group Inc., Schroder Investment Management Group, Goldman Sachs Group Inc., State Street Corp and Citadel Advisors LLC. Company insiders that have sold Otonomy stock in the last year include Carl Lebel and Eric J Loumeau. View Insider Buying and Selling for Otonomy.

Who bought Otonomy stock? Who is buying Otonomy stock?

Otonomy's stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Dimensional Fund Advisors LP, Alliancebernstein L.P., Northern Trust Corp, TD Asset Management Inc., State of Wisconsin Investment Board, Schwab Charles Investment Management Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for Otonomy.

How do I buy Otonomy stock?

Shares of Otonomy can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Otonomy's stock price today?

One share of Otonomy stock can currently be purchased for approximately $18.85.

MarketBeat Community Rating for Otonomy (NASDAQ OTIC)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  110 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about Otonomy and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Otonomy (NASDAQ:OTIC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.00 (59.15% upside)

Analysts' Ratings History for Otonomy (NASDAQ:OTIC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/15/2017J P Morgan Chase & CoUpgradeNeutral -> Overweight$28.00HighView Rating Details
6/30/2017Piper Jaffray CompaniesReiterated RatingOverweight$32.00LowView Rating Details
5/26/2016WallachBeth CapitalInitiated CoverageBuy$29.00N/AView Rating Details
10/9/2015Bank of America CorporationUpgradeNeutral -> Buy$31.00N/AView Rating Details
(Data available from 8/17/2015 forward)


Earnings History for Otonomy (NASDAQ:OTIC)
Earnings by Quarter for Otonomy (NASDAQ:OTIC)
Earnings History by Quarter for Otonomy (NASDAQ OTIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017Q2 2017($0.80)($0.77)$0.43 million$0.33 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.84)($0.89)$0.50 million$0.36 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.93)($0.88)$0.49 million$0.27 millionViewListenView Earnings Details
3/7/2016Q4($0.95)($0.87)ViewListenView Earnings Details
11/10/2015Q315($0.83)($0.57)ViewN/AView Earnings Details
8/12/2015Q116($0.67)($0.52)ViewN/AView Earnings Details
5/12/2015Q115($0.53)($0.52)ViewN/AView Earnings Details
3/18/2015Q415($0.64)($0.46)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Otonomy (NASDAQ:OTIC)
Current Year EPS Consensus Estimate: $-3.36 EPS
Next Year EPS Consensus Estimate: $-3.01 EPS


Dividend History for Otonomy (NASDAQ:OTIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Otonomy (NASDAQ:OTIC)
Insider Ownership Percentage: 12.70%
Institutional Ownership Percentage: 88.46%
Insider Trades by Quarter for Otonomy (NASDAQ:OTIC)
Institutional Ownership by Quarter for Otonomy (NASDAQ:OTIC)
Insider Trades by Quarter for Otonomy (NASDAQ:OTIC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/26/2017Eric J. LoumeauInsiderSell3,522$18.59$65,473.98View SEC Filing  
11/21/2016Carl LebelInsiderSell10,625$18.07$191,993.75View SEC Filing  
12/21/2015Carl LebelinsiderSell21,250$28.04$595,850.00View SEC Filing  
12/17/2015Paul E. CayerinsiderSell3,000$29.70$89,100.00View SEC Filing  
12/15/2015David Allen WeberCEOSell5,208$27.25$141,918.00View SEC Filing  
12/14/2015Robert Michael Savel IIinsiderSell5,000$26.00$130,000.00View SEC Filing  
11/30/2015Chau Quang KhuongDirectorSell67,106$28.93$1,941,376.58View SEC Filing  
11/24/2015Orbimed Advisors LlcDirectorSell200,800$28.56$5,734,848.00View SEC Filing  
11/19/2015Chau Quang KhuongDirectorSell138,398$28.62$3,960,950.76View SEC Filing  
11/17/2015Paul E. CayerinsiderSell3,000$28.69$86,070.00View SEC Filing  
11/16/2015David Allen WeberCEOSell5,208$28.57$148,792.56View SEC Filing  
11/13/2015David Allen WeberCEOSell10,416$30.95$322,375.20View SEC Filing  
11/11/2015David Allen WeberCEOSell5,208$24.95$129,939.60View SEC Filing  
11/11/2015Paul E. CayerCFOSell3,000$24.95$74,850.00View SEC Filing  
9/21/2015Carl LebelinsiderSell21,250$24.36$517,650.00View SEC Filing  
9/17/2015Paul E. CayerCFOSell3,000$24.95$74,850.00View SEC Filing  
9/15/2015David Allen WeberCEOSell5,216$24.95$130,139.20View SEC Filing  
9/14/2015Robert Michael Savel IIinsiderSell5,000$23.98$119,900.00View SEC Filing  
6/15/2015Robert Michael Savel IIInsiderSell25,000$23.73$593,250.00View SEC Filing  
8/19/2014A/S NovoInsiderBuy15,690$15.50$243,195.00View SEC Filing  
8/18/2014A/S NovoInsiderBuy171,875$16.00$2,750,000.00View SEC Filing  
8/18/2014Jay LichterDirectorSell50,001$16.00$800,016.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Otonomy (NASDAQ:OTIC)
Latest Headlines for Otonomy (NASDAQ:OTIC)
americanbankingnews.com logoOtonomy, Inc. (OTIC) Upgraded at J P Morgan Chase & Co
www.americanbankingnews.com - August 15 at 8:02 PM
americanbankingnews.com logoBidaskClub Downgrades Otonomy, Inc. (OTIC) to Hold
www.americanbankingnews.com - August 13 at 12:44 AM
finance.yahoo.com logoOtonomy, Inc. breached its 50 day moving average in a Bearish Manner : OTIC-US : August 10, 2017
finance.yahoo.com - August 11 at 7:19 AM
americanbankingnews.com logoOtonomy, Inc. (NASDAQ:OTIC) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - August 4 at 5:46 PM
finance.yahoo.com logoOtonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update
finance.yahoo.com - August 4 at 6:45 AM
americanbankingnews.com logoHead to Head Contrast: Otonomy (NASDAQ:OTIC) and Kite Pharma (KITE)
www.americanbankingnews.com - July 29 at 8:21 AM
finance.yahoo.com logoOtonomy to Report Second Quarter 2017 Financial Results and Provide Corporate Update
finance.yahoo.com - July 28 at 6:31 AM
finance.yahoo.com logoIs the Options Market Predicting a Spike in Otonomy (OTIC) Stock?
finance.yahoo.com - July 26 at 6:11 AM
streetinsider.com logoOtonomy (OTIC) sNDA for OTIPRIO Accepted by FDA
www.streetinsider.com - July 19 at 2:02 AM
finance.yahoo.com logoOtonomy Announces FDA Acceptance of OTIPRIO® Supplemental New Drug Application Filing for Acute Otitis Externa
finance.yahoo.com - July 19 at 2:02 AM
americanbankingnews.com logoOtonomy, Inc. (OTIC) Rating Reiterated by Piper Jaffray Companies
www.americanbankingnews.com - June 30 at 7:12 PM
finance.yahoo.com logoImplied Volatility Surging for Otonomy (OTIC) Stock Options
finance.yahoo.com - June 28 at 2:57 PM
americanbankingnews.com logoEric J. Loumeau Sells 3,522 Shares of Otonomy, Inc. (OTIC) Stock
www.americanbankingnews.com - June 27 at 7:51 PM
finance.yahoo.com logoOtonomy Announces Successful End-of-Phase 2 Review by FDA for OTIPRIO® in Acute Otitis Media with Tympanostomy Tubes
finance.yahoo.com - June 23 at 8:52 AM
finance.yahoo.com logoOtonomy to Host Key Opinion Leader Meeting for Investors on Ménière's Disease
finance.yahoo.com - June 21 at 1:20 AM
finance.yahoo.com logoETFs with exposure to Otonomy, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 8:38 AM
finance.yahoo.com logoOtonomy, Inc. breached its 50 day moving average in a Bullish Manner : OTIC-US : June 12, 2017
finance.yahoo.com - June 12 at 6:46 PM
finance.yahoo.com logoOtonomy, Inc. breached its 50 day moving average in a Bullish Manner : OTIC-US : June 2, 2017
finance.yahoo.com - June 2 at 9:21 PM
americanbankingnews.com logoPiper Jaffray Companies Initiates Coverage on Otonomy Inc (OTIC)
www.americanbankingnews.com - June 2 at 10:10 AM
finance.yahoo.com logoETFs with exposure to Otonomy, Inc. : May 23, 2017
finance.yahoo.com - May 23 at 6:33 PM
americanbankingnews.com logoOtonomy Inc (OTIC) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 18 at 8:26 PM
americanbankingnews.com logoZacks Investment Research Downgrades Otonomy Inc (OTIC) to Hold
www.americanbankingnews.com - May 14 at 8:58 PM
finance.yahoo.com logoOtonomy Announces OTIPRIO® Data Presentation and Symposium at the American Society of Pediatric Otolaryngology Annual Meeting
finance.yahoo.com - May 12 at 8:26 AM
finance.yahoo.com logoETFs with exposure to Otonomy, Inc. : May 11, 2017
finance.yahoo.com - May 11 at 7:34 PM
finance.yahoo.com logoOtonomy to Present at the Bank of America Merrill Lynch Health Care Conference
finance.yahoo.com - May 10 at 7:17 PM
finance.yahoo.com logoOtonomy, Inc. :OTIC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 11:50 AM
nasdaq.com logoNoteworthy Tuesday Option Activity: OTIC, YELP, NVDA
www.nasdaq.com - May 9 at 6:39 PM
americanbankingnews.com logoSunTrust Banks Weighs in on Otonomy Inc's FY2021 Earnings (OTIC)
www.americanbankingnews.com - May 8 at 12:28 PM
americanbankingnews.com logoOtonomy Inc (OTIC) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - May 7 at 6:26 PM
americanbankingnews.com logoOtonomy Inc (OTIC) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS
www.americanbankingnews.com - May 5 at 4:40 PM
marketbeat.com logoOtonomy reports 1Q loss
marketbeat.com - May 4 at 7:17 PM
finance.yahoo.com logoInvestor Network: Otonomy, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 7:16 PM
finance.yahoo.com logoOtonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update
finance.yahoo.com - May 4 at 7:16 PM
americanbankingnews.com logoOtonomy (OTIC) Earning Favorable Media Coverage, Report Finds
www.americanbankingnews.com - May 3 at 6:26 PM
americanbankingnews.com logoOtonomy (OTIC) Getting Positive Press Coverage, Study Shows
www.americanbankingnews.com - April 29 at 6:33 PM
finance.yahoo.com logoOtonomy, Inc. – Value Analysis (NASDAQ:OTIC) : April 28, 2017
finance.yahoo.com - April 28 at 8:09 PM
finance.yahoo.com logoOtonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update
finance.yahoo.com - April 27 at 7:33 PM
finance.yahoo.com logoOtonomy, Inc. breached its 50 day moving average in a Bullish Manner : OTIC-US : April 27, 2017
finance.yahoo.com - April 27 at 10:18 AM
americanbankingnews.com logoOtonomy (OTIC) Receives News Sentiment Rating of 0.24
www.americanbankingnews.com - April 26 at 7:52 PM
americanbankingnews.com logoOtonomy (OTIC) Receiving Somewhat Favorable News Coverage, Report Finds
www.americanbankingnews.com - April 22 at 1:59 PM
americanbankingnews.com logoOtonomy (OTIC) Earning Very Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 18 at 10:23 AM
nasdaq.com logoCommit To Buy Otonomy At $10, Earn 10.1% Annualized Using Options
www.nasdaq.com - April 8 at 6:20 PM
americanbankingnews.com logoShort Interest in Otonomy Inc (OTIC) Grows By 8.7%
www.americanbankingnews.com - April 5 at 10:52 PM
finance.yahoo.com logoEdited Transcript of OTIC earnings conference call or presentation 2-Mar-17 9:30pm GMT
finance.yahoo.com - March 31 at 7:13 PM
247wallst.com logo5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts
247wallst.com - March 21 at 11:10 AM
finance.yahoo.com logoOTONOMY, INC. Financials
finance.yahoo.com - March 8 at 3:45 PM
finance.yahoo.com logoOtonomy reports 4Q loss - Yahoo Finance
finance.yahoo.com - March 3 at 12:18 AM
us.rd.yahoo.com logoOtonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
us.rd.yahoo.com - March 2 at 7:17 PM
us.rd.yahoo.com logo4:27 pm Otonomy reports Q4, issues guidance
us.rd.yahoo.com - March 2 at 7:17 PM
biz.yahoo.com logoQ4 2016 Otonomy Inc Earnings Release - After Market Close
biz.yahoo.com - March 2 at 8:46 AM



Otonomy (OTIC) Chart for Thursday, August, 17, 2017

This page was last updated on 8/17/2017 by MarketBeat.com Staff